Vanda Pharmaceuticals Stock
Price
Target price
€4.64
€4.64
6.700%
0.3
6.700%
€17.30
05.12.25 / Tradegate
WKN: A0JJT3 / Symbol: VNDA / Name: Vanda Pharma / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Vanda Pharmaceuticals Stock
A very strong showing by Vanda Pharmaceuticals today, with an increase of €0.30 (6.700%) compared to yesterday's price.
Vanda Pharmaceuticals is currently one of the favorites of our community with 13 Buy predictions and no Sell predictions.
Based on the current price of 4.64 € the target price of 17 € shows a potential of 266.38% for Vanda Pharmaceuticals which would more than double the current price.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Vanda Pharmaceuticals stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Vanda Pharmaceuticals in the next few years
Pros
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
S********** s********
Cons
?
W********* I********* f** t** n*** y****
?
B****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Vanda Pharmaceuticals vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Vanda Pharmaceuticals | 6.700% | 1.310% | 19.588% | 2.655% | 1.310% | -54.951% | -57.818% |
| Ardelyx Inc. | -0.470% | 1.501% | -0.696% | -1.154% | 3.525% | 187.536% | -1.306% |
| Krystal Biotech | 5.350% | 6.399% | 15.665% | 18.562% | 32.194% | 164.737% | - |
| Evolus Inc | 0.890% | -5.042% | -1.739% | -52.521% | -46.190% | -16.296% | 86.346% |
Comments
Vanda Pharmaceuticals (NASDAQ:VNDA) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Show more
Ratings data for VNDA provided by MarketBeat
Vanda Pharmaceuticals (NASDAQ:VNDA) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $20.00 price target on the stock.
Show more
Ratings data for VNDA provided by MarketBeat
Vanda Pharmaceuticals (NASDAQ:VNDA) had its price target lowered by analysts at Cantor Fitzgerald from $13.00 to $11.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for VNDA provided by MarketBeat
